Big Pharma Giant Wants New Patents for Formulation Changes That Won’t Improve Clinical Benefit of Cancer Drug — Adding to Existing Patent Thicket of 129 Filed Applications On Friday, Big Pharma giant Merck announced that it will seek new patents on its blockbuster cancer drug Keytruda, which last year brought in over $17 billion for
Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug company Vertex manufacturers four key cystic fibrosis (CF) treatments, Trikafta, Symdeko, Orkambi…
Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and More Out-of-Control Launch Prices on New Products For Immediate Release Contact: Jon Conradi 860-235-3884…
Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1 Diabetes, Blowing Past Wall Street Expectations For Immediate Release Contact: Jon Conradi 860-235-3884…
Interchangeable Biosimilars Help Provide Patients with Greater Choice and More Affordable Alternatives to High-Priced Brand Name Drugs For Immediate Release Contact: Jon Conradi 860-235-3884…
Brand Name Drug Company to Acquire Manufacturer of Narcan as Both Work to Block Competition from More Affordable Alternatives In case you missed it, on Monday pharmaceutical company Indivior…
Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike Drug Prices A final round of Big Pharma third quarter earnings reports from GlaxoSmithKline…
Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases, Pfizer’s Bourla Pressed on “Sheer Magnitude” of COVID-19 Vaccine Price Hike on Earnings Call Big Pharma companies…
New Report Finds Brand Name Drug Companies Increased Prices on New Oncology Treatments by 25 Percent Over Four Years This week, U.S. Representative Katie Porter (D-CA) released a report,…
JAMA Analysis Finds No Correlation Between Cancer Drug Prices and Effectiveness A new study published in the Journal of the American Medical Association (JAMA) Internal Medicine found a lack of…